🔥🐔 BizChicken 🐔🔥
Companies Similar to Creative Medical Technology Holdings, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
CERo Therapeutics Holdings, Inc.
Engineered T Cell Therapeutics
CERo Therapeutics Holdings, Inc. is an immunotherapy company focused on developing engineered T cell therapeutics for cancer treatment, particularly targeting hematologic malignancies using innovative immune system integration strategies.
Symbol: CERO
Recent Price: $0.06
Industry: Biotechnology
CEO: Mr. Christopher B. Ehrlich M.B.A.
Sector: Healthcare
Employees: 8
Address: 201 Haskins Way, South San Francisco, CA 94080
Phone: 650-407-2376
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
INmune Bio, Inc.
INKmune
INmune Bio, Inc. is a clinical-stage immunotherapy company focused on developing drugs to reprogram the patient's innate immune system for the treatment of hematologic malignancies, solid tumors, chronic inflammation, and Alzheimer's disease.
Symbol: INMB
Recent Price: $4.65
Industry: Biotechnology
CEO: Dr. Raymond Joseph Tesi M.D.
Sector: Healthcare
Employees: 11
Address: 225 NE Mizner Boulevard, Boca Raton, FL 33432
Phone: 858 964 3720
Last updated: 2024-12-31
PharmaCyte Biotech, Inc.
Cell-in-a-Box
Pharma Cyte Biotech, Inc. is a biotechnology company focused on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites. Their therapies are based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, used for treating various cancers and diabetes.
About | Management | Directors | ESG | About | Directors | Contact | ESG | About | About | About | About
Symbol: PMCB
Recent Price: $1.55
Industry: Biotechnology
CEO: Mr. Joshua N. Silverman
Sector: Healthcare
Employees: 2
Address: 3960 Howard Hughes Parkway, Las Vegas, NV 89169
Phone: 917 595 2850
Leadership
- Joshua N. Silverman, Independent Director
- Dr. Michael M. Abecassis, Independent Director
- Robert Weinstein, Director
- Wayne R. Walker, Director
- Jonathan L. Schechter, Independent Director
- Dr. Abecassis, Director
- Kenneth L. Waggoner, Independent Director
- Daniel C. Farb, Independent Director
- Daniel C. Allen, Independent Director
- Jack E. Stover, Independent Director
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Telomir Pharmaceuticals, Inc. Common Stock
TELOMIR-1
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.
Symbol: TELO
Recent Price: $4.64
Industry: Biotechnology
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 1
Address: 855 N Wolfe Street, Baltimore, null 21205
Phone: (737)-289-0835
Last updated: 2024-12-31
Arcellx, Inc.
CART-dd BCMA
Arcellx, Inc. is a clinical-stage biotechnology company dedicated to developing immunotherapies for cancer and other incurable diseases, with a focus on its lead product candidate, CART-dd BCMA, for treating relapsed or refractory multiple myeloma.
About | About | News | Contact | Contact | Culture | Culture | Culture | Culture | About | About | About | About | About | News
Symbol: ACLX
Recent Price: $78.35
Industry: Biotechnology
CEO: Mr. Rami Elghandour
Sector: Healthcare
Employees: 130
Address: 25 West Watkins Mill Road, Gaithersburg, MD 20878
Phone: 240 327 0603
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
BioXcel Therapeutics, Inc.
IGALMI
Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.
Symbol: BTAI
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Vimal D. Mehta Ph.D.
Sector: Healthcare
Employees: 74
Address: 555 Long Wharf Drive, New Haven, CT 06511
Phone: 475 238 6837
Last updated: 2024-12-31
Celularity Inc.
CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.
About | Leadership | Directors | About | About | About | About | Directors | Careers | About | About | About | About | About | About
Symbol: CELU
Recent Price: $2.05
Industry: Biotechnology
CEO: Dr. Robert Joseph Hariri M.D., Ph.D.
Sector: Healthcare
Employees: 120
Address: 170 Park Avenue, Florham Park, NJ 07932
Phone: 908 768 2170
Leadership
- Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
- David Beers, CFA, Chief Financial Officer
- Stephen Brigido, DPM, President, Degenerative Diseases
- John Haines, Global Manager and Chief Administrative Officer
- K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
- John Colerangle, DVM, Ph.D., Regulatory Affairs
- Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
- Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
- Carmine Palummo, Corporate Operations
- Tim Wilk, Technical Operations
- Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
- Peter Diamandis, M.D., Director
- Dean Kehler, Director
- Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
- Diane Parks, Director
Last updated: 2024-12-31
Cellectar Biosciences, Inc.
CLR 131
Cellectar Biosciences, Inc. is a clinical biopharmaceutical company concentrating on the development and commercialization of drugs for cancer treatment.
Symbol: CLRB
Recent Price: $0.29
Industry: Biotechnology
CEO: Mr. James V. Caruso
Sector: Healthcare
Employees: 20
Address: 100 Campus Drive, Florham Park, NJ 07932
Phone: 608 441 8120
Leadership
- James Caruso, President, CEO and Director
- Chad Kolean, Chief Financial Officer
- Shane Lea, Chief Commercial Officer
- Jarrod Longcor, Chief Operating Officer
- Andrei Shustov, Senior Vice President, Medical
- Douglas J. Swirsky, Chairman of the Board
- Asher Alban Chanan-Khan, MD., Director
- Frederick W. Driscoll, Director
- Stefan D. Loren, Ph.D., Director
- John Neis, Director
- Cellectar Biosciences, Inc., Company Information
Last updated: 2024-12-31
Immunome, Inc.
IMM-ONC-01, IMM-BCP-01
Immunome, Inc. is a biopharmaceutical company focused on developing antibody therapeutics for oncology and infectious diseases, offering innovative solutions such as IMM-ONC-01 for cancer and IMM-BCP-01 for COVID-19 treatment.
Symbol: IMNM
Recent Price: $10.28
Industry: Biotechnology
CEO: Dr. Clay B. Siegall Ph.D.
Sector: Healthcare
Employees: 78
Address: 665 Stockton Drive, Exton, PA 19341
Phone: 610 321 3700
Last updated: 2024-12-31
Immuneering Corporation
IMM-1-104 and IMM-6-415
Immuneering Corporation is a biopharmaceutical company focused on developing oncology and neuroscience product candidates, with key products like IMM-1-104 for cancer treatment and IMM-6-415 for solid tumors.
Symbol: IMRX
Recent Price: $2.25
Industry: Biotechnology
CEO: Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Sector: Healthcare
Employees: 66
Address: 245 Main Street, Cambridge, MA 02142
Phone: 617 500 8080
Last updated: 2024-12-31
Immunic, Inc.
IMU-838
Immunic, Inc. develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, in Phase 2 clinical trials for multiple conditions, including relapsing-remitting multiple sclerosis.
About | Vision/Values | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: IMUX
Recent Price: $1.03
Industry: Biotechnology
CEO: Dr. Daniel Vitt Ph.D.
Sector: Healthcare
Employees: 85
Address: 1200 Avenue of the Americas, New York, NY 10036
Phone: 332 255 9818
Last updated: 2024-12-31
NexImmune, Inc.
Artificial Immune Modulation
Nex Immune, Inc., a clinical-stage biotechnology company, develops therapies for cancer and immune-mediated diseases using its Artificial Immune Modulation platform. The company is advancing cell therapy candidates including NEXI-001, NEXI-002, and NEXI-003.
About | Leadership | About | About | About | About | Leadership | About | About | Contact | Contact | Contact | Careers | Careers | About | About | About | About
Symbol: NEXI
Recent Price: $0.15
Industry: Biotechnology
CEO: Mr. John Trainer M.B.A.
Sector: Healthcare
Employees: 6
Address: 9119 Gaither Road, Gaithersburg, MD 20877
Phone: 301 825 9810
Leadership
- Kristi Jones, Chief Executive Officer
- Mathias Oelke, Ph.D., Chief Scientific Officer
- Daniel Bednarik Ph.D., Senior Vice President, Molecular Engineering & Protein Design
- Jack Ragheb, Senior Vice President, Translational Science
- Tonya Catterton, Vice President, Quality & Compliance
- Tim Stover, Vice President, Corporate Controller
- Karen Haslbeck, Head, Human Resources
- Matt Schiller, Head, Business Development
Last updated: 2024-12-31
Instil Bio, Inc.
ITIL-168, ITIL-306
Instil Bio, Inc. is a clinical-stage biopharmaceutical company that develops cell therapies for treating cancer patients, focusing on autologous tumor infiltrating lymphocyte (TIL) treatments.
Symbol: TIL
Recent Price: $18.99
Industry: Biotechnology
CEO: Mr. Bronson Crouch
Sector: Healthcare
Employees: 49
Address: 3963 Maple Avenue, Dallas, TX 75219
Phone: 972 499 3350
Last updated: 2024-12-31
2seventy bio, Inc.
idecabtagene vicleucel
2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.
Symbol: TSVT
Recent Price: $2.89
Industry: Biotechnology
CEO: Mr. William D. Baird III, M.B.A.
Sector: Healthcare
Employees: 274
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Last updated: 2024-12-31
Adaptive Biotechnologies Corporation
immunoSEQ
Adaptive Biotechnologies Corporation is a commercial-stage company that develops an immune medicine platform for diagnosing and treating various diseases, including COVID-19 and lymphoid cancers.
Leadership | Contact | About | About | About | About | Careers | Careers | About | About | About | About | About
Symbol: ADPT
Recent Price: $6.11
Industry: Biotechnology
CEO: Mr. Chad M. Robins M.B.A.
Sector: Healthcare
Employees: 709
Address: 1165 Eastlake Avenue East, Seattle, WA 98109
Phone: 206 659 0067
Last updated: 2024-12-31
Creative Medical Technology Holdings, Inc.
Imm Celz
Creative Medical Technology Holdings, Inc. is a biotechnology company focusing on using adult stem cell treatments for immunology, urology, orthopedics, and neurology, offering solutions like Caver Stem, Fem Celz, Stem Spine, Imm Celz, and Ova Stem.
Symbol: CELZ
Recent Price: $2.34
Industry: Biotechnology
CEO: Mr. Timothy Warbington
Sector: Healthcare
Employees: 4
Address: 211 East Osborn Road, Phoenix, AZ 85012
Phone: 480 399 2822
Last updated: 2024-12-31
Immix Biopharma, Inc.
IMX-110, IMX-111, IMX-120
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing tissue-specific therapeutics for oncology and inflammation, with clinical trials across the United States and Australia.
Symbol: IMMX
Recent Price: $2.36
Industry: Biotechnology
CEO: Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Sector: Healthcare
Employees: 14
Address: 11400 West Olympic Boulevard, Los Angeles, CA 90064
Phone: 310 651 8041
Last updated: 2024-12-31